Perpetual Medicines Completes $8 Million Seed Round to Advance Integrated Computational Design-Synthesis Platform for Peptide Drug Discovery
Company Announces Core Leadership Team, Led by CEO, Kerry L. Blanchard, MD, PhD SHANGHAI & BOSTON--(BUSINESS WIRE)--Perpetual Medicines today announced...




















